Quality of life in men with metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone: a systematic review and meta-analysis

Citation:

Ternov KK, Nolsøe AB, Bratt O, Fode M, Lindberg H, Kistorp C, Palapattu G, Klausen TW, Sønksen J, Østergren PB. Prostate Cancer Prostatic Dis. 2021 Apr 5. doi: 10.1038/s41391-021-00359-8. Epub ahead of print. PMID: 33820951.